Publications by authors named "Ilene D Kurzman"

Claim this Profile
A
Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma.
Mark R Albertini, Cindy L Zuleger, Erik A Ranheim, Oyewale Shiyanbola, Paul M Sondel, Ilene D Kurzman

Melanoma Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of a randomized, placebo-controlled study evaluating efficacy and safety of a cancer preventative vaccine in dogs.
Jenna H Burton, Stephen Albert Johnston, David M Vail, Jens C Eickhoff, Kathryn F Sykes, Ilene D Kurzman

Vet Immunol Immunopathol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting.
Kara Magee, Ian R Marsh, Michelle M Turek, Joseph Grudzinski, Eduardo Aluicio-Sarduy, Ilene D Kurzman

PLoS One· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot study of safety and feasibility of DNA microseeding for treatment of spontaneous canine melanoma.
Cindy L Zuleger, Chulhi Kang, Erik A Ranheim, Ilene D Kurzman, Michael D Macklin

Vet Med Sci· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GS-9219/VDC-1101--a prodrug of the acyclic nucleotide PMEG has antitumor activity in spontaneous canine multiple myeloma.
Douglas H Thamm, David M Vail, Ilene D Kurzman, Darius Babusis, Adrian S Ray

BMC Vet Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor.
Deborah A Grosenbaugh, A Timothy Leard, Philip J Bergman, Mary K Klein, Karri Meleo, Ilene D Kurzman

Am J Vet Res· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical investigation of PEGylated tumor necrosis factor alpha in dogs with spontaneous tumors: phase I evaluation.
Douglas H Thamm, Ilene D Kurzman, Mike A Clark, E J Ehrhart, Susan L Kraft

Clin Cancer Res· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RT-PCR-based tyrosine kinase display profiling of canine melanoma: IGF-1 receptor as a potential therapeutic target.
Douglas H Thamm, Michael K Huelsmeyer, Ann M Mitzey, Barbara Qurollo, Barbara J Rose, Ilene D Kurzman

Melanoma Res· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of GS-9219 in a pet dog model of non-Hodgkin's lymphoma.
David M Vail, Douglas H Thamm, Hans Reiser, Adrian S Ray, Grushenka H I Wolfgang, Ilene D Kurzman

Clin Cancer Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical signs, treatments, and outcome in cats with transitional cell carcinoma of the urinary bladder: 20 cases (1990-2004).
Heather M Wilson, Ruthanne Chun, Victoria S Larson, Ilene D Kurzman, David M Vail

J Am Vet Med Assoc· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does L-asparaginase influence efficacy or toxicity when added to a standard CHOP protocol for dogs with lymphoma?
Valerie S MacDonald, Douglas H Thamm, Ilene D Kurzman, Michelle M Turek, David M Vail

J Vet Intern Med· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluation.
Douglas H Thamm, Ilene D Kurzman, Ivan King, Zujin Li, Mario Sznol

Clin Cancer Res· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma synthesis of carbon magnetic nanoparticles and immobilization of doxorubicin for targeted drug delivery.
Yonghui Ma, Sorin Manolache, Ferencz S Denes, Douglas H Thamm, Ilene D Kurzman

J Biomater Sci Polym Ed· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of a liposome-encapsulated formulation of cisplatin in clinically normal dogs.
Amanda K Marr, Ilene D Kurzman, David M Vail

Am J Vet Res· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imatinib mesylate inhibits platelet-derived growth factor activity and increases chemosensitivity in feline vaccine-associated sarcoma.
Rieko Katayama, Michael K Huelsmeyer, Amanda K Marr, Ilene D Kurzman, Douglas H Thamm

Cancer Chemother Pharmacol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IGF-1 receptor contributes to the malignant phenotype in human and canine osteosarcoma.
E Gregory MacEwen, Josep Pastor, Jonathan Kutzke, Rachel Tsan, Ilene D Kurzman

J Cell Biochem· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intralesional lipid-complexed cytokine/superantigen immunogene therapy for spontaneous canine tumors.
Douglas H Thamm, Ilene D Kurzman, E Gregory Macewen, Rhonda Feinmehl, Todd L Towell

Cancer Immunol Immunother· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liposome-encapsulated doxorubicin (Doxil) and doxorubicin in the treatment of vaccine-associated sarcoma in cats.
Valerie J Poirier, Douglas H Thamm, Ilene D Kurzman, K Ann Jeglum, Ruthanne Chun

J Vet Intern Med· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial.
David M Vail, Ilene D Kurzman, Phyllis C Glawe, Maura G O'Brien, Ruthanne Chun

Cancer Chemother Pharmacol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis